Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $58

Canaccord Genuity analyst William Plovanic maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $43 to $58.